https://www.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/AstraZeneca-COVID-19-vaccine-AZD1222-showed-robust-immune-responses-in-all-participants-in-Phase-I-30956922/?utm_source=telegram&utm_medium=social&utm_campaign=share